Cardiovascular disease in HIV infection

Area of Science:

• Cardiology
• Infectious Diseases
• Public Health

Background:

• Cardiovascular disease (CVD) is a significant concern in Human Immunodeficiency Virus (HIV) infected patients.
• The advent of highly active antiretroviral therapy (HAART) has shifted focus towards non-AIDS complications like CVD.
• HIV infection is now a primary driver of acquired cardiovascular conditions, notably heart failure.

Purpose of the Study:

• To summarize key findings on principal HIV-associated cardiovascular manifestations.
• To emphasize the importance of early recognition of these conditions.
• To facilitate prompt intervention and therapeutic strategies for affected individuals.

Main Methods:

• Literature review of HIV-associated cardiovascular manifestations.
• Synthesis of data on observed cardiac changes in HIV patients.
• Summary of clinical findings related to specific cardiovascular conditions.

Main Results:

• Observed changes include left ventricular systolic dysfunction, dilated cardiomyopathy, and congestive heart failure.
• Other manifestations encompass myocarditis, lipodystrophy, dyslipidemia, insulin resistance, and accelerated atherosclerosis (e.g., myocardial infarction).
• Additional findings include a prothrombotic state, pericardial effusion, pulmonary hypertension, autonomic dysfunction, and malignancy.

Conclusions:

• HIV infection significantly contributes to acquired cardiovascular disease and heart failure.
• Early identification of HIV-related cardiovascular complications is essential.
• Timely intervention and therapy can improve outcomes for patients with HIV-associated cardiovascular disease.